Loading...
XSHE
000881
Market cap857mUSD
Jul 10, Last price  
6.19CNY
1D
0.65%
1Q
-19.30%
Jan 2017
-77.33%
Name

CGN Nuclear Technology Development Co Ltd

Chart & Performance

D1W1MN
XSHE:000881 chart
P/E
P/S
1.05
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-3.55%
Revenues
5.55b
-9.97%
2,131,102,7072,500,985,0761,701,080,7721,741,564,3791,722,175,4162,665,027,4281,997,645,3902,029,650,4402,136,512,2843,015,133,2616,363,194,3056,776,114,2267,021,621,5936,651,679,5906,651,679,5907,998,857,6826,944,907,1746,352,518,9436,168,400,5785,553,315,758
Net income
-287m
L-20.73%
126,628,407161,133,455110,385,152203,319,714230,026,051200,924,790108,354,52775,022,097245,402,565311,913,565388,861,599319,703,589102,681,779271,123,164271,123,171176,723,243199,594,594-737,163,925-362,167,590-287,093,833
CFO
138m
-69.79%
70,134,519185,648,730605,109,070140,773,096200,694,34649,320,402824,569,083435,411,6960340,111,23566,847,432225,074,306140,962,771728,864,340547,361,013475,720,066563,624,947371,271,537456,344,040137,865,441
Dividend
Jun 07, 20230.04 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CGN Nuclear Technology Development Co., Ltd. manufactures and sells cable materials and industrial electron accelerators in China. It provides ground nanoaccelerators, electronic curtain accelerators, DG resonant transformer accelerators, and industrial flaw detection accelerators. The company is also involved in the provision of electron beam treatment of specialty waste; antibiotic residue treatment technology; pharmaceutical wastewater treatment technology; medical sewage and solid waste disposal; park sewage treatment; printing and dyeing wastewater treatment technology; coal chemical coking wastewater treatment technology; chemical wastewater treatment technology; domestic sewage treatment technology; and hazardous waste concentrate treatment services. In addition, it provides new energy, irradiated, elastomer, and synthetic materials; modified polycarbonate and polyester, modified polypropylene, continuous fiber reinforced thermoplastic composites, and melt blown and radiation resistant polypropylene; and proton therapy tumor system equipment, raw materials and parts, radioactive medical isotopes, and hospital and nuclear drug products. Further, the company engages in production and sale of plastic; and real estate development, as well as contracting, irradiation processing, ocean shipping, maritime cargo transportation, ship investment and chartering, fishery, and project construction businesses. The company was formerly known as China Dalian International Cooperation (Group) Holdings Ltd. and changed its name to CGN Nuclear Technology Development Co., Ltd. in February 2017. CGN Nuclear Technology Development Co., Ltd. was founded in 1993 and is based in Shenzhen, China.
IPO date
Sep 02, 1998
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122021‑002020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT